Mirum Pharmaceuticals, Inc (MIRM) Stock Price

87.54 ▼ -0.42 (-0.48%)
Open: 89.04 Vol: 666.81K Day's range: 86.51 - 90.31 Sep 29, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MIRM Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY NEUTRAL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 87.56▲ 87.56▲ 87.49▲ 88.78▼ 93.64▼
MA10 87.58▲ 87.41▲ 87.65▼ 91.53▼ 96.92▼
MA20 87.55▲ 87.50▲ 87.85▼ 95.12▼ 103.63▼
MA50 87.44▲ 88.05▼ 89.48▼ 100.07▼ 93.64▼
MA100 87.71▼ 89.78▼ 93.40▼ 103.97▼ 72.68▲
MA200 87.67▼ 93.93▼ 96.09▼ 97.97▼ 50.78▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.005▼ 0.060▲ 0.145▲ -0.621▼ -3.238▼
RSI 51.738▲ 49.028▼ 44.480▼ 31.741▼ 40.132▼
STOCH 42.828     45.440     40.907     13.996▼ 17.944▼
WILL %R -52.212     -73.611     -50.573     -84.756▼ -93.751▼
CCI -44.828     -14.667     32.394     -96.086     -110.019▼
Latest Filters Detected On MIRM
CDL $MIRM Doji Candlestick Pattern Detected Set Alert
Mirum Pharmaceuticals, Inc News
Mirum Pharmaceuticals annonce que le critère d’évaluation principal a été atteint dans l’étude de phase III AZURE-1 portant sur le brelovitug dans le traitement de l ...
Tuesday, September 29, 2026 11:45 AM
Mirum Pharmaceuticals, Inc. (Nasdaq : MIRM), une société de premier plan spécialisée dans les maladies rares, a annoncé aujourd’hui que le critère d’évaluation principal avait été atteint dans la phas ...
Mirum clears Phase III test with hepatitis delta antibody
Tuesday, September 29, 2026 01:54 AM
US rare disease company Mirum Pharmaceuticals (Nasdaq: MIRM) said Monday that its experimental antibody brelovitug met the primary endpoint in the Phase III portion of AZURE-1, supporting plans to ...
Mirum Pharmaceuticals gibt bekannt, dass der primäre Endpunkt in der Phase-3-Studie AZURE-1 zu Brelovitug bei chronischer Hepatitis-Delta-Virus-Infektion erreicht wurde
Monday, September 28, 2026 07:34 PM
– Der primäre Endpunkt der Phase-3-Studie wurde in beiden Dosierungsgruppen in Woche 24 erreicht – Daten nach 48 Wochen aus dem Phase-2b-Teil der AZURE-1-Studie belegen eine ...
MIRM historical stock data
date open high low close volume
29/09/26 89.04 90.31 86.51 87.54 666,806
28/09/26 90.00 91.2499 84.71 87.96 1,236,617
25/09/26 89.90 90.81 88.275 89.70 761,935
24/09/26 89.24 90.69 87.635 89.36 681,112
23/09/26 91.31 91.50 87.87 89.32 739,145
22/09/26 92.49 92.82 90.55 91.39 763,782
21/09/26 93.07 94.57 91.04 92.00 685,077
18/09/26 98.76 98.76 91.73 91.83 1,797,929
17/09/26 99.53 100.50 97.255 98.82 926,224
16/09/26 93.95 98.83 93.76 97.37 991,185
Quote Details
52wk Low:63.232
52wk High:130.00
Vol:666.81K
Avg Vol(3m):13.9M
1Y Chng:+14.90%
1M Chng:-13.22%
Add to Watch List
More Information
Index US Composite
Market Cap. 5.71B